Indoco Remedies said it was fully committed in resolving the issue and will respond to the queries at the earliest. Photo: BloombergMumbai: Indoco Remedies Ltd Friday said the US Food and Drug Administration (FDA) has issued a warning letter to its manufacturing plant in Goa for violation of good manufacturing practices. “Based on the review of compliance response, FDA accepted our response to four observations. Indoco Remedies said it was fully committed in resolving the issue and will respond to the queries at the earliest. On Friday, shares of Indoco Remedies ended down 1.2% at Rs249.95 on the BSE, while benchmark Sensex index closed down 0.1% at 29620.50 points.

Source: Mint March 31, 2017 14:37 UTC